Key result
Trial compares VT catheter ablation to escalating AADs in ischemic heart disease.
Why the study?
To assess and compare the effects of catheter ablation for ventricular tachycardia with escalation of antiarrhythmic drugs in patients with ischaemic heart disease.
Does catheter ablation improve outcomes compared to escalation of antiarrhythmic drugs in patients with ischaemic heart disease and ventricular tachycardia?
Does catheter ablation improve outcomes compared to escalation of antiarrhythmic drugs in patients with ischaemic heart disease and ventricular tachycardia?
This is a protocol for a Cochrane Review to assess the effects of catheter ablation versus escalation of antiarrhythmic drugs for ventricular tachycardia in patients with ischaemic heart disease.
No immediate change to VT management in IHD; protocol extends evidence synthesis but leaves optimal strategy open.
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess and compare the effects of catheter ablation for ventricular tachycardia (VT) with escalation of antiarrhythmic drugs (AADs) in patients with ischaemic heart disease (IHD).
No takes yet. Share an insight, caveat, or question.
Kakarla et al. (2021) studied this question. Catheter ablation for ventricular tachycardia will be compared with escalation of antiarrhythmic drugs in patients with ischaemic heart disease to assess their clinical effects.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: